MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Genocea Biosciences Initiates Phase 1 Study of Vaccine Candidate Gen-004 to Prevent Infections Caused by Pneumococcus.
Guest UserDecember 5, 2013
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Covagen and Tanabe Research Laboratories Expand Strategic Research Collaboration for Development of Bispecific FynomAbs.

Guest UserDecember 6, 2013
Next

F-star announces formation of new asset-centric vehicle, F-star Alpha Ltd, with €9.4m Series A investment.

Guest UserOctober 23, 2013

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact